32 Biosciences Website
1 known investors
32 Biosciences develops gut mucosal-immune science to prevent and treat gastrointestinal diseases, offering a GI discovery platform that measures metabolomic signatures of the gut mucosal-immune system and a therapeutic platform based on a Mucosal Immune Modulator (MIM) that restores and protects the gastrointestinal mucosal-immune barrier. Its lead therapeutic asset is CS-0003.
BiotechDigital Health
Investors · 1
Frequently asked questions
- What does 32 Biosciences Website do?
- 32 Biosciences develops gut mucosal-immune science to prevent and treat gastrointestinal diseases, offering a GI discovery platform that measures metabolomic signatures of the gut mucosal-immune system and a therapeutic platform based on a Mucosal Immune Modulator (MIM) that restores and protects the gastrointestinal mucosal-immune barrier. Its lead therapeutic asset is CS-0003.
- Who are 32 Biosciences Website's investors?
- 32 Biosciences Website's investors include SmartHealth Catalyzer.